![Philippe Calais](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 10 $ in data 31/05/2026
Philippe P.
Calais is the founder of Phileas Pharma, Inc., founded in 2019, serving as Chairman.
Current jobs include President, Chief Executive Officer & Director at MatriSys Bioscience, Inc.; Executive Chairman & Chief Executive Officer at TransCode Therapeutics, Inc. since 2025; and Professor at Florida Atlantic University since 2019.
Former jobs include President, Chief Executive Officer & Director at Ambrilia Biopharma, Inc. (2008–2009); President & Chief Executive Officer at Univalor, Inc. (2011–2012); President & Chief Executive Officer at Isarna Therapeutics BV (2012–2018); Chairman at Neurochem (International) Ltd. (2003–2007); Director at CohBar, Inc. (2019–2020); Lead Independent Director at Adhera Therapeutics, Inc. (2017–2018); Director at Medpharmgene, Inc. (2011–2012); Director at Autotelic, Inc. (2016–2018); Director at Cite Des Biotechs De Laval (2002–2012); Director at Cognisense (2010–2012); President-Global Business at BELLUS Health, Inc. (2003–2007); Head-Global Strategic Marketing Unit at Hoffmann-La Roche, Inc.; and General Manager at Servier Canada, Inc. (2000–2002).
Education includes undergraduate studies at Université Pierre et Marie Curie and both undergraduate and doctorate degrees from Université François-Rabelais de Tours.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 28/05/2026 | 2 ( 0% ) | 10 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| TRANSCODE THERAPEUTICS, INC. | Amministratore Delegato | 06/10/2025 |
Phileas Pharma, Inc. | Fondatore | 01/05/2019 |
MatriSys Bioscience, Inc.
 MatriSys Bioscience, Inc. BiotechnologyHealth Technology Develops rational micro biome therapies | Amministratore Delegato | - |
Florida Atlantic University
 Florida Atlantic University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/05/2019 |
| Società | Posizione | Fine |
|---|---|---|
| COHBAR | Amministratore Delegato | 15/05/2019 |
Autotelic, Inc.
 Autotelic, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapeutics drugs | Direttore/Membro del Consiglio | 01/06/2018 |
Isarna Therapeutics BV
 Isarna Therapeutics BV Financial ConglomeratesFinance Functions as an investment holding company | Amministratore Delegato | 01/06/2018 |
| ADHERA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 02/05/2018 |
Medpharmgene, Inc.
 Medpharmgene, Inc. Miscellaneous Commercial ServicesCommercial Services Provides commercial physical research services | Direttore/Membro del Consiglio | 01/02/2012 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 19 |
|---|---|
BELLUS Health, Inc.
 BELLUS Health, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for the treatment of refractory chronic disease | Health Technology |
CohBar, Inc.
 CohBar, Inc. BiotechnologyHealth Technology Develops biotechnology products that intends to treat age-related diseases through the discovery of novel mitochondrial-derived peptides | Health Technology |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Florida Atlantic University
Florida Atlantic University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ambrilia Biopharma, Inc.
 Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel treatments for viral diseases and cancer | Health Technology |
Université Pierre et Marie Curie
 Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université François-Rabelais de Tours
 Université François-Rabelais de Tours Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neurochem (International) Ltd.
 Neurochem (International) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides licensing and partnering activities | Commercial Services |
Servier Canada, Inc.
 Servier Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for cardiology, diabetes, depression, venous disease and menopause | Health Technology |
Univalor, Inc.
 Univalor, Inc. Miscellaneous Commercial ServicesCommercial Services Univalor, Inc. engages in the provision of research and development services. The company was founded on April 27, 2001 and is headquartered in Montréal, Canada. | Commercial Services |
Adhera Therapeutics, Inc.
 Adhera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes hypertensive drugs | Health Technology |
Medpharmgene, Inc.
Medpharmgene, Inc. Miscellaneous Commercial ServicesCommercial Services Provides commercial physical research services | Commercial Services |
Autotelic, Inc.
Autotelic, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapeutics drugs | Health Technology |
MatriSys Bioscience, Inc.
MatriSys Bioscience, Inc. BiotechnologyHealth Technology Develops rational micro biome therapies | Health Technology |
TransCode Therapeutics, Inc.
 TransCode Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes diagnostics and therapeutics for the detection and treatment of cancer | Health Technology |
Phileas Pharma, Inc. | |
Isarna Therapeutics BV
Isarna Therapeutics BV Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Cite Des Biotechs De Laval | |
Cognisense |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
